Optimal price subsidies for appropriate malaria testing and treatment behaviour

Malaria Journal

Table 1 Retail prices excluding subsidies and parameter values used in numerical simulations

Description	Parameter	Best estimate	Lower bound	Upper bound	Source
Retail price of monotherapy^#,&	$C_{MT}^{{}}$	US$0.3	US$0.1	US$1.6	[3, 44]
Retail price of ACT^#	$C_{ACT}^{{}}$	US$3.5	US$1.0	US$10.0	[3, 17]
Retail price of RDT	$C_{RDT}^{{}}$	US$1.8	US$0.5	US$2.93	[3, 17]
Effectiveness of monotherapy^&	$E_{MT}$	50%	20%	70%	[45, 46]
Effectiveness of ACT	$E_{ACT}$	95%	90%	99%	[47]
RDT sensitivity	$ss^{RDT}$	95%	86%	99%	[48, 49]
RDT specificity	$sp^{RDT}$	95%	75%	99.8%	[49]

^# This price guide reports manufacturer prices and in order to arrive at estimates of retail prices a mark-up of 100% is assumed as found in a market survey [50]
^& Non-artemisinin monotherapy

ISSN: 1475-2875

Description	Parameter	Best estimate	Lower bound	Upper bound	Source
Retail price of monotherapy^#,&	\(C_{MT}^{{}}\)	US$0.3	US$0.1	US$1.6	[3, 44]
Retail price of ACT^#	\(C_{ACT}^{{}}\)	US$3.5	US$1.0	US$10.0	[3, 17]
Retail price of RDT	\(C_{RDT}^{{}}\)	US$1.8	US$0.5	US$2.93	[3, 17]
Effectiveness of monotherapy^&	\(E_{MT}\)	50%	20%	70%	[45, 46]
Effectiveness of ACT	\(E_{ACT}\)	95%	90%	99%	[47]
RDT sensitivity	\(ss^{RDT}\)	95%	86%	99%	[48, 49]
RDT specificity	\(sp^{RDT}\)	95%	75%	99.8%	[49]